Compare Heron Therapeutics Inc (HRTX) vs Public Storage (PSA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Public Storage — how do they compare? Heron Therapeutics Inc trades at $0.41 (market cap $68.01M), while Public Storage trades at $289.86 (market cap $53.35B). The key difference: Public Storage is far larger — about 784.4× Heron Therapeutics Inc's market cap, and Public Storage pays a 4.2% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Public Storage for 130 Days on average.
| HRTX | PSA | |
|---|---|---|
Market Cap | $68.01M | $53.35B |
Volume | 1,891,941 | 1,176,034 |
Sector | Health | Real Estate |
52-Week High | $1.49 | $330.47 |
52-Week Low | $0.27 | $258.44 |
Typical Hold Time | 35 Days | 130 Days |
Enterprise Value | $174.75M | $67.62B |
Dividend Yield | — | 4.2% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.3582, down 8.15% today, with a bullish technical signal from moving averages but mixed earnings. The company reported Q2 2026 revenue of $37.7 million but missed EPS estimates, continuing a trend of net losses. Analyst sentiment remains strongly positive with 89% buy ratings, though Zacks issued a Strong Sell rating in July 2026.
The outlook hinges on revenue stabilization and path to profitability. Investment opportunity lies in analyst optimism and product sales growth, but risks include persistent losses, high valuation multiples, and competitive pressures in the biotechnology sector.
Public Storage (PSA) trades at $285.52, up 1.25% with a bearish technical signal despite strong profitability metrics. The REIT maintains robust fundamentals with 41.8% net income margin and consistent earnings beats, though valuation ratios appear elevated. Recent developments include the completion of Public Storage Canada acquisition and a $400 million Canadian debt offering, signaling expansion efforts. Cash flow trends show operational stability with $3.19B from operations in 2025, though net cash flow remains negative due to significant investing activity.
The stock presents a mixed outlook with analyst consensus target of $328.33 suggesting 15% upside potential, yet technical indicators and some bearish sentiment create near-term uncertainty. Key risks include REIT sector sensitivity to interest rates and competitive pressures, while the 4.05% dividend yield provides income support. Institutional activity shows mixed positioning with recent large purchases offset by selective reductions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Public Storage
Public Storage is the largest owner of self-storage facilities in the U.S. with more than 2,800 self-storage facilities in 39 states and approximately 200 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage and to an additional 28 million net rentable square feet of industrial space in the United States through PS Business Parks.
Read more on PSA →
